An exploratory study of primary care pharmacist-led epilepsy consultations

International Journal of Pharmacy Practice

Volumn 20, Issue 5, 2012, Pages 294-302

  Fogg, Angela ^b   Staufenberg, Ekkehart F ^a   Small, Ian ^b   Bhattacharya, Debi ^b  

^a Little Plumstead Hospital   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

adherence; epilepsy; pharmacy services

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; ALCOHOLISM; ARTICLE; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DRUG INFORMATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT INFORMATION; PATIENT SATISFACTION; PHARMACIST; PHARMACIST ATTITUDE; POLYPHARMACY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SUSTAINED RELEASE FORMULATION;

ADULT; AGED; ANTICONVULSANTS; EPILEPSY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PHARMACEUTICAL SERVICES; PHARMACISTS; PRIMARY HEALTH CARE; PROFESSIONAL ROLE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84866132310     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2012.00207.x     Document Type: Article

References (39)

1. Purcell B, et al,. Epilepsy prevalence and prescribing patterns in England and Wales. Health Stat 2002; 15: 23-30.
2. Leppik IE, Schmidt D,. Summary of the first international workshop on compliance in epilepsy. Epilepsy Res 1988; 2: 179-182.
3. Stanaway LLD, Johnson RH,. Non-compliance with anticonvulsant therapy as a cause of seizures. N Z Med J 1985; 98: 150-152.
4. Irving P, et al,. An audit of admissions of patients with epilepsy to a district general hospital. Seizure 1999; 8: 166-169.
5. Buck D, et al,. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997; 6: 87-93.
6. Buelow JMJJ,. Self-management of epilepsy: a review of the concept, its outcomes. Dis Manage Health Outcomes 2000; 8: 327-336.
7. Cramer JA, et al,. How often is medication taken as prescribed? A novel assessment technique. J Am Med Assoc 1989; 261: 3273-3277.
8. Garnett WR,. Antiepileptic drug treatment: outcomes, adherence. Pharmacotherapy 2000; 20: 191-199.
9. Sleath B, et al,. Drug information sources and antidepressant adherence. Community Ment Health J 2003; 39: 359-368.
10. Harris J, et al,. User Experiences of Health and Social Care Services. London: Department of Health Publications, 2003.
11. Anon. NSE members' survey. http://www.epilepsynse.org.uk/PAGES/WHATSNEW/ epilepsyweek/members.cfm (accessed 19 October 2007).
12. Anon. NSE national survey results. http://www.epilepsynse.org.uk/pages/ whatsnew/epilepsyweek/GPsurvey.cfm (accessed 19 October 2007).
13. Department of Health. Equity and excellence: liberating the NHS. London: Department of Health, 2010.
14. Krska J, et al,. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-211.
15. Macrae F, et al,. Patient views of pharmacist-led medication review clinics: a preliminary qualitative study. Int J Pharm Pract 2003; 11: R6.
16. Ali F, et al,. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003; 10: 101-106.
17. Baker GA, et al,. The initial development of a health-related quality of life model as an outcome measure for epilepsy. Epilepsy Res 1993; 16: 65-81.
18. Cramer JA, et al,. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res 2000; 41: 29-38.
19. Goldberg DP, Hillier VF,. A scaled version of the General Health Questionnaire. Psychol Med 1979; 9: 139-145.
20. Goldberg DP, et al,. A psychiatric interview suitable for use in community surveys. Br J Prev Soc Med 1970; 24: 18-26.
21. Goldberg DP, et al,. A comparison of two psychiatric screening tests. Br J Psychiatry 1976; 129: 61-67.
22. Goldberg DP, Huxley P,. Mental Illness in the Community: The Pathway to Psychiatric Care. London: Tavistock, 1980.
23. Goldberg DP, Williams P,. A User's Guide to the General Health Questionnaire-GHQ. London: Nelson Publishing Company, 1988.
24. Scambler A, et al,. Towards and evaluation of the effectiveness of an epilepsy nurse in primary care. Seizure 1996; 5: 255-258.
25. Horne R, et al,. The satisfaction with information about medicines scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001; 10: 135-140.
26. Cramer J, et al,. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36: 1111-1117.
27. Rand CS,. Issues in the measurement of adherence. In:, Shumaker SA, Schron EB, eds. The Handbook of Health Behaviour Change. New York: Springer, 1990: 102-110.
28. Horne R, Weinman J,. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence of preventer medication. Psychol Health 2002; 17: 17-32.
29. Bhattacharya D, et al,. Non-adherence in older people: intentional or uninttentional? Int J Pharm Pract 2004; 12: R63.
30. Goodwin M, et al,. A survey of a novel epilepsy clinic. Seizure 2002; 11: 519-522.
31. DH Long-termConditions NSF Team. The National Service Framework for Long-Term Conditions. Quality Requirement 11: caring for people with neurological conditions in hospital or other health and social care settings. London: DH Long-termConditions NSF Team, 2005: 59-61.
32. Horne RaW J,. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567.
33. Cramer JA, et al,. Compendium of Quality of Life Instruments, vol. 1-5. Chichester: Wiley, 1998.
34. Haynes RB, et al,. Can simple clinical measurements detect patient noncompliance? Hypertension 1980; 2: 757-764.
35. Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme. Room for Review. A Guide to Medication Review: The Agenda for Patients, Practitioners and Managers, 1st edn. London: Medicines Partnership, 2002.
36. McBee GW, Justice B,. The effect of interviewer bias on mental illness questionnaire responses. J Psychol 1977; 95: 67-75.
37. Anon. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. CG 20. London: National Institute for Health and Clinical Excellence, 2004.
38. Pharm J News Team. Most pharmacists do not know enough about new type 2 diabetes drugs to carry out medicines use reviews. Pharm J 2010; 285: 4.
39. Economic and Social Data Service. Health Survey for England 2005. London: Department of Health, 2007.